Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery (EPHAS)
Evaluation of Microporous Polysaccharide Hemospheres (MPH) Agent in Preventing Postoperative Complications After Rectal Surgery (EPHAS Study).
Sponsor: Aragon Health Science Institute
This observational or N/A phase trial investigates Postoperative Sepsis and is currently completed. Aragon Health Science Institute leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
Status: Unknown → Completed
-
Jul 2024 — Aug 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2022 — Jan 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Apr 2021 — Jan 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aragon Health Science Institute
- Grupo Español de Rehabilitación Multimodal
- Universidad de Zaragoza
For direct contact, visit the study record on ClinicalTrials.gov .